stockrowiRhythm Holdings, Inc. (IRTC) vs 10x Genomics (TXG)
- iRhythm Holdings, Inc. IRTC 89.45 −31.29%
- 10x Genomics TXG 57.82 −0.41%
iRhythm Holdings, Inc. and 10x Genomics are both Medical Devices companies. 10x Genomics is the larger, with a market value of $7.6B against $4.3B — 1.8× the size. iRhythm Holdings, Inc. grew revenue faster over the last twelve months: 21.6% against −4.28%. iRhythm Holdings, Inc. has the higher net margin (−4.52% vs −12.2%) and the higher return on invested capital (−11.4% vs −20.2%). Across the 19 metrics below, iRhythm Holdings, Inc. leads on 11 and 10x Genomics on 8.
Valuation
Profitability
| Metric | IRTC | TXG | Medical Devices median |
|---|---|---|---|
| Gross margin | 72.26% | 70.03% | 57.76% |
| Operating margin | (5.74%) | (14.33%) | (15.07%) |
| Net margin | (4.52%) | (12.18%) | (14.45%) |
| Free cash flow margin | 0.86% | 19.68% | (3.88%) |
| Return on equity | (25.81%) | (9.40%) | (10.35%) |
| Return on assets | (3.70%) | (7.47%) | (17.26%) |
| Return on invested capital | (11.42%) | (20.20%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack